CAFs also secrete hepatocyte growth factor (HGF), which not only activate EMT-related c-Met pathway but also give lung cancer cells resistance to conventional epidermal growth factor tyrosine kinase inhibitors [7, 59]. This evidence concerns the gene HGF and lung cancer.